Prognostic inflammatory–immune score-based risk stratification optimizes adjuvant therapy for non-gastric gastrointestinal stromal tumors: a multicenter study - Top-Institutions - MDSpire

Prognostic inflammatory–immune score-based risk stratification optimizes adjuvant therapy for non-gastric gastrointestinal stromal tumors: a multicenter study

  • By

  • Zhiming Cai

  • Zhengnan Xu

  • Huimei Lin

  • Huibin Liu

  • Zihan Lin

  • Jinhu Chen

  • Shichai Hong

  • Weibin Song

  • Xinyu Chen

  • Yanchang Xu

  • Zhenrong Yang

  • Yongjian Zhou

  • June 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Armed Forces Institute of Pathology
    Armed Forces Institute of Pathology

    Washington, DC

    Key Differentiators

    • Pathology
    • Oncology

  • #2

    National Institutes of Health
    National Institutes of Health

    Bethesda, MD

    Key Differentiators

    • Oncology
    • Research

  • #3

    American College of Surgeons
    American College of Surgeons

    Chicago, IL

    Key Differentiators

    • Surgery
    • Oncology

  • #4

    Scandinavian Sarcoma Group
    Scandinavian Sarcoma Group

    Copenhagen, Denmark

    Key Differentiators

    • Oncology
    • Sarcoma

  • #5

    European Organisation for Research and Treatment of Cancer
    European Organisation for Research and Treatment of Cancer

    Brussels, Belgium

    Key Differentiators

    • Oncology
    • Research

Original Source(s)

Prognostic inflammatory–immune score-based risk stratification optimizes adjuvant therapy for non-gastric gastrointestinal stromal tumors: a multicenter study

  • by Zhiming Cai, Zhengnan Xu, Huimei Lin, Huibin Liu, Zihan Lin, Jinhu Chen, Shichai Hong, Weibin Song, Xinyu Chen, Yanchang Xu, Zhenrong Yang, Yongjian Zhou

  • June 2, 2026

Related Content

Diagnosis and treatment of neurofibromatosis type 1 with malignant transformation and multiple gastrointestinal stromal tumors: a case report and literature review

ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma

Chemotherapy-related cognitive impairment and non-pharmacological interventions targeting the nervous system: a systematic review